Hemostasis Valve Market Size to Reach USD 263.18 Million by 2031, Driven by Rising Interventional Procedures and Radial Access Adoption
Hemostasis Valve Market Overview
The global hemostasis valve market size is estimated at USD 203.9 million in 2026, increasing from USD 193.75 million in 2025, and is projected to reach USD 263.18 million by 2031, registering a CAGR of 5.24% during the forecast period (2026–2031). Market growth is supported by rising interventional cardiology and radiology procedure volumes, the growing burden of cardiovascular diseases, and increasing adoption of minimally invasive endovascular surgeries.
Hemostasis valves are essential components of catheter-based procedures, helping maintain vascular access while controlling blood loss during the insertion and exchange of medical devices. Their use across angiography, angioplasty, electrophysiology, and neuro-interventional procedures supports consistent demand from healthcare facilities. North America currently represents the largest regional market, while Asia-Pacific is expected to record the fastest growth.
Hemostasis Valve Market Trends Shaping Industry Demand
Rising Volume of Interventional Cardiology and Radiology Procedures
The increasing number of interventional cardiology and radiology procedures is a major factor supporting the hemostasis valve market. Procedures such as angiography and angioplasty require reliable vascular access throughout treatment, creating demand for valves that maintain a secure seal during catheter and guidewire exchanges.
The growing use of catheter-based treatments for cardiovascular conditions is also increasing the need for disposable and specialized access components. As healthcare facilities handle more complex interventions, they require valves that can support repeated device exchanges while maintaining procedural efficiency and controlling blood loss.
Growing Adoption of Minimally Invasive Endovascular Procedures
The shift toward minimally invasive endovascular procedures is influencing demand for advanced hemostasis valves. These procedures offer alternatives to open surgery and rely on catheter-based access systems to reach targeted blood vessels. Hemostasis valves help maintain access and limit blood leakage during these interventions.
Healthcare providers are increasingly focused on products that support reliable sealing, ease of handling, and compatibility with different catheter sizes. This is encouraging manufacturers to develop valves suited to complex procedures and evolving interventional techniques.
Increasing Adoption of Radial Access and Low-Profile Devices
The growing use of radial access is creating demand for hemostasis valves compatible with smaller French-size devices. Compared with traditional femoral access, radial access is associated with fewer access-site complications and can support earlier patient mobilization in suitable procedures.
This shift is influencing product design, particularly the development of low-profile valves that maintain seal integrity while accommodating smaller catheters and guidewires. Manufacturers are also focusing on ergonomic features that allow physicians to operate valves efficiently during device exchanges.
Growing Demand for One-Handed Hemostasis Valves
Healthcare professionals are showing increasing interest in valve designs that simplify device manipulation during interventional procedures. One-handed hemostasis valves allow operators to manage access and device exchanges with greater convenience, particularly during complex procedures that require frequent instrument changes.
This product category is expected to grow faster than other product types. Improvements in valve mechanisms, seal performance, and ease of operation are supporting its adoption across catheterization laboratories and specialized interventional settings.
Expansion of Ambulatory Surgical Centers
The expansion of ambulatory surgical centers is creating additional opportunities for hemostasis valve manufacturers. Healthcare systems are increasingly considering outpatient treatment pathways for suitable procedures, supported by same-day discharge protocols and efforts to improve operational efficiency.
Hospitals continue to account for the largest end-user share because they perform a wide range of complex interventions. However, ambulatory surgical centers are expected to record faster growth as more suitable catheter-based procedures are performed in outpatient environments.
Check out more details and stay updated with the latest industry trends: Hemostasis Valve Market – Mordor Intelligence
Hemostasis Valve Market Segmentation
The hemostasis valve market is segmented by product type, application, end user, and geography.
By Product Type
Hemostasis Valve Y-Connectors
Double Y-Connector Valves
One-Handed Hemostasis Valves
Integrated Extension-Line Valves
Push-Pull Hemostasis Valves
Others
By Application
Angiography
Angioplasty
Electrophysiology Procedures
Neuro-interventional Procedures
Peripheral Vascular Interventions
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers
Catheterization Laboratories
Specialty Clinics
Other End Users
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Key Players in the Hemostasis Valve Market
The hemostasis valve industry includes established medical device manufacturers and specialized suppliers serving interventional cardiology, radiology, and vascular procedure markets. Companies compete through product development, improvements in valve functionality, distribution networks, and the ability to meet the requirements of different catheter-based procedures.
The major companies covered in the Mordor Intelligence report include:
Boston Scientific Corporation
Merit Medical Systems
Teleflex Incorporated
Terumo Corporation
Freudenberg Medical
Argon Medical Devices
B. Braun Melsungen AG
Antmed Corporation
Abbott Laboratories
DeRoyal Industries Inc.
Minivalve International
Asahi Intecc Co. Ltd.
Cook Medical
Medtronic plc
Nipro Corporation
Qosina Corp.
Galt Medical Corp.
Becton Dickinson & Co.
Cardionovum GmbH
Nordson Medical
Smiths Medical (ICU Medical)
Conclusion
The hemostasis valve market is expected to experience steady growth through 2031, supported by increasing interventional cardiology and radiology procedures, wider adoption of minimally invasive treatments, and the expansion of catheter-based interventions. Demand for low-profile and one-handed valve designs is also influencing product development as healthcare professionals seek improved handling and reliable sealing during complex procedures.
Hospitals remain the leading end-user segment, while ambulatory surgical centers are expected to expand at a faster pace. North America continues to represent the largest regional market, whereas Asia-Pacific offers significant growth opportunities. Manufacturers focusing on product performance, procedural efficiency, and compatibility with evolving vascular access techniques are likely to remain important participants in the competitive landscape.
Comments
Post a Comment